Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults

Completed · Phase 1 · Has a placebo group

Conditions studied: Pneumococcal Vaccines

In brief

The purpose of this study is to determine if a Streptococcus pneumoniae Whole Cell Vaccine (SPWCV) given with alum is safe and well tolerated by healthy adults.

Key facts

Study ID

NCT01537185

Run by

PATH Vaccine Solutions

People needed

42

Starts

2012-02-01

Expected to finish

2013-04-01

Last updated by the study team

2014-06-05

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may not qualify if…

• Currently consumes alcohol in excess of 2 drinks per day for men or 1 drink per day for women.
• current use or likely requirement for medications with potential for liver injury or effect immune system
• History of event or condition such as anaphylaxis, severe allergic reactions, serious reactions to any vaccines, or other events that might increase risk of reaction to an investigational disease
• History of diabetes, cancer, autoimmune or immunosuppressive disease or chronic such as HIV, Hepatitis B or C

Where it is running

• Comprehensive Clinical Development — Tacoma, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.